Cargando…

Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial

BACKGROUND: Hydroxyurea, chronic blood transfusions, and bone marrow transplantation are efficacious, disease-modifying therapies for sickle cell disease but involve complex risk-benefit trade-offs and decisional dilemma compounded by the lack of comparative studies. A patient decision aid can infor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnamurti, Lakshmanan, Ross, Diana, Sinha, Cynthia, Leong, Traci, Bakshi, Namita, Mittal, Nonita, Veludhandi, Divya, Pham, Anh-Phuong, Taneja, Alankrita, Gupta, Kamesh, Nwanze, Julum, Matthews, Andrea Marie, Joshi, Saumya, Vazquez Olivieri, Veronica, Arjunan, Santhi, Okonkwo, Ifechi, Lukombo, Ines, Lane, Peter, Bakshi, Nitya, Loewenstein, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934048/ https://www.ncbi.nlm.nih.gov/pubmed/31799940 http://dx.doi.org/10.2196/14462

Ejemplares similares

Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode
por: Bakshi, Nitya, et al.
Publicado: (2018)

A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study
por: Veludhandi, Anirudh, et al.
Publicado: (2021)

Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease
por: Sinha, Cynthia B., et al.
Publicado: (2020)

Acute Chest Syndrome in Children with Sickle Cell Disease
por: Jain, Shilpa, et al.
Publicado: (2017)

Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2017)

Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative Study
por: Bakshi, Nitya, et al.
Publicado: (2020)

Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study
por: Sinha, Cynthia B., et al.
Publicado: (2019)

From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea
por: Sinha, Cynthia B., et al.
Publicado: (2018)

Intraindividual pain variability and phenotypes of pain in sickle cell disease: a secondary analysis from the Pain in Sickle Cell Epidemiology Study
por: Bakshi, Nitya, et al.
Publicado: (2022)

Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study
por: Hawkins, Lauren M., et al.
Publicado: (2020)

Sex and frequency of pain episodes are associated with acute pain trajectories in adolescents with sickle cell disease
por: Astles, Rachel, et al.
Publicado: (2023)

Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2023)

Decision-making about gene therapy in transfusion dependent thalassemia
por: Quarmyne, Maa-Ohui, et al.
Publicado: (2022)

The role of the arginine metabolome in pain: implications for sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2016)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Effects of Music Therapy on Quality of Life in Adults with Sickle Cell Disease (MUSIQOLS): A Mixed Methods Feasibility Study
por: Rodgers-Melnick, Samuel N, et al.
Publicado: (2022)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017)

Radiologic-Pathologic Correlation of COVID-19-Associated Acute Disseminated Encephalomyelitis
por: Bezold, Amy, et al.
Publicado: (2023)

Assessing Patient Preferences for Treatment Options for Pediatric Sickle Cell Disease: A Critical Review of Quantitative and Qualitative Studies
por: Katoch, Deeksha, et al.
Publicado: (2021)

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2022)

Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
por: Chiang, Kate Chander, et al.
Publicado: (2023)

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision
por: Creary, Susan, et al.
Publicado: (2015)

Prevalence and predictors of chronic pain intensity and disability among adults with sickle cell disease
por: Matthie, Nadine, et al.
Publicado: (2020)

Patient-reported outcomes in children with sickle cell disease at presentation for an acute pain episode
por: Bakshi, Nitya, et al.
Publicado: (2022)

CAR‐T‐OPENIA: Chimeric antigen receptor T‐cell therapy‐associated cytopenias
por: Taneja, Alankrita, et al.
Publicado: (2021)

Characterizing User Engagement With a Digital Intervention for Pain Self-management Among Youth With Sickle Cell Disease and Their Caregivers: Subanalysis of a Randomized Controlled Trial
por: Lalloo, Chitra, et al.
Publicado: (2022)

Association of genetic variation in COMT gene with pain related to sickle cell disease in patients from the walk-PHaSST study
por: Zhang, Yingze, et al.
Publicado: (2018)

Primary renal lymphoma: A population‐based analysis using the SEER program (1973‐2015)
por: Taneja, Alankrita, et al.
Publicado: (2020)

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
por: Schoettler, Michelle, et al.
Publicado: (2022)

Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation
por: Stenger, Elizabeth O., et al.
Publicado: (2015)

A Cross-Sectional Study of Determinants of Exclusive Breastfeeding among Working Mothers in Enugu
por: Onwuka, Chidinma Ifechi
Publicado: (2022)

Surveillance for Sickle Cell Disease — Sickle Cell Data Collection Program, Two States, 2004–2018
por: Snyder, Angela B., et al.
Publicado: (2022)

Induction of Hepcidin Expression in the Renal Cortex of Sickle Cell Disease Mice
por: Ahmad, Asrar, et al.
Publicado: (2023)

New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019)

N-95 masks: how much do we know?
por: Bakshi, Satvinder Singh, et al.
Publicado: (2020)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial
por: Rees, Chris A., et al.
Publicado: (2023)

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
por: Wun, Ted, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_re190kugd560o3vkdt0c4cqi0e